Jump to content

CUV - CLINUVEL PHARMACEUTICALS LIMITED


colaiscute

Recommended Posts

  • Replies 51.4k
  • Created
  • Last Reply

Top Posters In This Topic

  • royco

    2914

  • Kiwi1

    1702

  • seeva222

    1669

  • Reality Check

    1771

Top Posters In This Topic

Posted Images

Seeva had previously posted a good summary of countries/patients that were receiving SCENESSE, however the most recent version I could find was from circa 2017, see below.

 

Perhaps we should set up a Google doc or similar where âââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’‹Ã…“ShareCafeâââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’¢Ã¢Ã¢â€š¬Ã…¾Ãƒâ€šÃ‚¢ readers can keep track of this?

 

Sizing the EPP market. Made some adjustments. Please correct any errors. (damn formatting)

 

Current Potential

Cost (in AUD) $22,500

 

Current Potential

Q3 Implants (est) 1.7 1.7

Quarter Revenue $11,054,250 $84,705,900

 

Current Potential

Ann Implants (est) 3.0 3.0

Ann Revenue $19,507,500 $149,481,000

 

Current Potential

 

USA - | 1,000

Germany 55 | 400

England - | 400

France - | 350

Netherlands 104 | 250

Italy 50 | 50

Norway - | 41

Austria 40 | 40

Switzerland 40 | 40

Sweden - | 40

Belgium - | 40

Czech - | 40

Portugal - | 40

Hungary - | 40

Sweden - | 40

Scotland - | 25

Denmark - | 25

Finland - | 25

Slovakia - | 25

Ireland - | 20

 

Total 289 | 2,931

 

As for the question regarding how many countries CUV is targeting, I thought someone had already made a list (years ago?) based on all the expert centres featured on http://EPP.care

I just realised this is no longer comprehensive enough, e.g. Poland doesnâââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’¢Ã¢Ã¢â€š¬Ã…¾Ãƒâ€šÃ‚¢t have an expert centre listed on epp.care, hmm this is sloppy if CUV want to make it easy for those suffering EPP to understand where treatment is available in the EU/EEA, however it could be intentional as we know they love keeping (a subset) of shareholders in the dark...

Link to comment
Share on other sites

I agree with your statement,but after a little time to think of our ongoing problem with Clinuvel and it's management team full of secrecy from we shareholders, why don't we just sell out CUV to the Chinese just like our Governments of all persuasions are doing with our wonderful water,farms,cattle and sheep properties etc etc etc!!! Apparently all we need is a very rich man in CHINA and we prudent shareholders of Clinuvel could end up making a bloody fortune.PW will get his Soccer team and we could get $50 a share......... Australia will end up with nothing so what have we got to lose?? Am I angry, look at the dwindling share price, bloody oath I am. Over to all you wise investors in Clinuvel, wake up.(before it is too late ) :grrr:
Link to comment
Share on other sites

This is not a correct list of countries actually receiving Scenesse.

 

USA - | 1,000

Germany 55 | 400 - APPROVED

England - | 400 - UNDER REVIEW

France - | 350 - UNDER REVIEW

Netherlands 104 | 250 - APPROVED

Italy 50 | 50 - APPROVED

Norway - | 41 - REJECTED

Austria 40 | 40 - APPROVED

Switzerland 40 | 40 - APPROVED

Sweden - | 40 - UNDER REVIEW

Belgium - | 40 - status unknown

Czech - | 40 - status unknown

Portugal - | 40 - NOT SUBMITED

Hungary - | 40 - status unknown

Sweden - | 40 - (sweden again)

Scotland - | 25 - UNDER REVIEW

Denmark - | 25 - UNDER REVIEW

Finland - | 25 - status unknown

Slovakia - | 25 - status unknown

Ireland - | 20 - status unknown

 

Excluding the USA as a non european country, you have only 5 approval cases. Slovenia and Poland are missing in the âââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’‚ÂÂgreen lightâââہ¡Ãƒâ€šÃ‚¬ÃƒÆ’‚ group.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×
×
  • Create New...